Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem
Inspira (NASDAQ:IINN) announced on October 22, 2025 a strategic collaboration with Bites Learning to embed Bites’ AI-powered training and guidance platform across Inspira’s global ecosystem. The integration will be built into future versions of the INSPIRA ART100 cardiopulmonary support system and the HYLA real-time blood sensor to standardize onboarding, accelerate training, and reduce support burdens for hospitals, distributors, and users.
Key features include adaptive AI training modules, personalized on-demand knowledge feeds, analytics for training adoption and audit-readiness, a built-in commercial value layer, joint marketing, and provisions to evaluate deeper commercial or strategic transactions.
Inspira (NASDAQ:IINN) ha annunciato il 22 ottobre 2025 una collaborazione strategica con Bites Learning per integrare la piattaforma di formazione e guida potenziata dall'AI di Bites all'interno dell'ecosistema globale di Inspira. L'integrazione sarà incorporata nelle future versioni del sistema di supporto cardiopulmonare INSPIRA ART100 e del sensore di sangue in tempo reale HYLA, al fine di standardizzare l'onboarding, accelerare la formazione e ridurre gli oneri_di_supporto per ospedali, distributori e utenti.
Le caratteristiche principali includono moduli di formazione AI adattivi, flussi di conoscenza personalizzati su richiesta, analisi per l'adozione della formazione e l'idoneità all'audit, uno strato di valore commerciale integrato, marketing congiunto e disposizioni per valutare transazioni commerciali o strategiche più profonde.
Inspira (NASDAQ:IINN) anunció el 22 de octubre de 2025 una colaboración estratégica con Bites Learning para incorporar la plataforma de capacitación y orientación impulsada por IA de Bites en el ecosistema global de Inspira. La integración se incorporará en futuras versiones del sistema de soporte cardiopulmonar INSPIRA ART100 y del sensor de sangre en tiempo real HYLA para estandarizar la incorporación, acelerar la formación y reducir las cargas de soporte para hospitales, distribuidores y usuarios.
Entre sus características destacan módulos de capacitación con IA adaptativos, flujos de conocimiento personalizados bajo demanda, analíticas para la adopción de la formación y la preparación para auditorías, una capa de valor comercial integrada, marketing conjunto y disposiciones para evaluar transacciones comerciales o estratégicas más profundas.
Inspira (NASDAQ:IINN)는 2025년 10월 22일 Bites Learning과의 전략적 협력을 발표하여 Bites의 AI 기반 훈련 및 안내 플랫폼을 Inspira의 글로벌 생태계에 도입합니다. 이 통합은 향후 버전의 INSPIRA ART100 심폐 지원 시스템과 HYLA 실시간 혈액 센서에 내장되어 병원, 유통업체 및 사용자에 대한 온보딩 표준화, 교육 가속화 및 지원 부담 감소를 목표로 합니다.
주요 특징으로는 적응형 AI 학습 모듈, 요청에 따른 개인화 지식 피드, 훈련 채택 및 감사 대비를 위한 분석, 내장된 상업적 가치 계층, 공동 마케팅, 더 깊은 상업적 또는 전략적 거래를 평가하기 위한 조항이 포함됩니다.
Inspira (NASDAQ:IINN) a annoncé le 22 octobre 2025 une collaboration stratégique avec Bites Learning pour intégrer la plateforme de formation et d'orientation alimentée par l'IA de Bites dans l'écosystème mondial d'Inspira. L'intégration sera intégrée dans les futures versions du système de soutien cardio-pulmonaire INSPIRA ART100 et du capteur sanguin en temps réel HYLA afin de standardiser l'onboarding, d'accélérer la formation et de réduire les charges de support pour les hôpitaux, les distributeurs et les utilisateurs.
Les fonctionnalités clés comprennent des modules de formation IA adaptatifs, des flux de connaissances personnalisés à la demande, des analyses pour l'adoption de la formation et la préparation à l'audit, une couche de valeur commerciale intégrée, le co-marketing et des dispositions pour évaluer des transactions commerciales ou stratégiques plus approfondies.
Inspira (NASDAQ:IINN) gab am 22. Oktober 2025 eine strategische Zusammenarbeit mit Bites Learning bekannt, um die KI-gestützte Trainings- und Beratungsplattform von Bites in das globale Ökosystem von Inspira zu integrieren. Die Integration wird in zukünftige Versionen des INSPIRA ART100-Herz-Lungen-Unterstützungssystems und des HYLA-Echtzeit-Blut-Sensors eingebettet, um das Onboarding zu standardisieren, Schulungen zu beschleunigen und den Supportaufwand für Krankenhäuser, Distributoren und Anwender zu reduzieren.
Zu den Kernfunktionen gehören adaptive KI-Trainingsmodule, personalisierte On-Demand-Wissensfeeds, Analytik zur Trainingsakzeptanz und Auditbereitschaft, eine integrierte kommerzielle Wertschicht, gemeinsames Marketing und Bestimmungen zur Bewertung tieferer kommerzieller oder strategischer Transaktionen.
Inspira (NASDAQ:IINN) أعلنت في 22 أكتوبر 2025 عن تعاون استراتيجي مع Bites Learning لدمج منصة التدريب والإرشاد المعزَّزة بالذكاء الاصطناعي لبِيتس في منظومة Inspira العالمية. سيُدمج هذا التكامل في الإصدارات المستقبلية من نظام دعم القلب والرئتين INSPIRA ART100 و< b>HYLA لقياس الدم في الوقت الحقيقي، بهدف توحيد إجراءات الانضمام، وتسريع التدريب، وتقليل أعباء الدعم للمستشفيات والموزعين والمستخدمين.
تشمل الميزات الرئيسية وحدات تدريب AI قابلة للتكيّف، وتدفقات معرفة مخصصة حسب الطلب، وتحليلات لاعتماد التدريب والاستعداد للتدقيق، وطبقة قيمة تجارية مدمجة، وتسويقاً مشتركاً، وأحكام لتقييم معاملات تجارية أو استراتيجيات أعمق.
Inspira（NASDAQ:IINN） 在 2025年10月22日 宣布与 Bites Learning 建立战略合作，将 Bites 的 AI 驱动培训与指导平台嵌入 Inspira 的全球生态系统。该集成将被内嵌到 INSPIRA ART100 心肺支持系统和 HYLA 实时血液传感器的未来版本中，以实现入职标准化、加速培训并减少医院、分销商和用户的支持负担。
主要特征包括自适应 AI 培训模块、按需个性化知识流、用于培训采用率和审计就绪性的分析、内置的商业价值层、联合营销，以及评估更深层次商业或战略交易的条款。
- None.
- None.
Insights
Partnership embeds AI training into Inspira's devices; outcome depends on execution, adoption, and measurable usage.
Inspira and Bites will integrate an AI training and support layer into future versions of the INSPIRA™ ART100 and the HYLA™ sensor, creating built-in adaptive training, simulations, and analytics that aim to speed onboarding and standardize user competency.
Impact depends on three clear dependencies: technical integration quality, clinical and operational uptake by hospitals and distributors, and the platform’s ability to generate reliable usage and training metrics. Implementation complexity, regulatory or hospital IT approval processes, and user acceptance could limit near-term benefits.
Watch for measurable adoption signals such as published deployment counts, training completion and adoption metrics, and any commercial announcements tying AI features to customer contracts or service pricing within the next 6–12 months. The collaboration’s mention of "long-term strategic options" signals possible deeper commercial alignment, which would become material if concrete transactions or license terms appear on a
RA'ANANA, Israel, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic collaboration with Bites Learning Ltd. (“Bites”), a leader in AI-based digital training and performance enablement solutions.
Through this collaboration, Bites’ advanced AI-powered learning and guidance platform will be embedded as a built-in standard across Inspira’s ecosystem, including future versions of the INSPIRA™ ART100 cardiopulmonary support system and the HYLA™ real-time blood sensor. The integration is designed to transform training, accelerate onboarding, and enhance operational performance for hospitals, distributors, and users worldwide.
This collaboration creates a new AI-driven foundation for Inspira’s commercial operations - creating an intelligent training and support layer that simplifies onboarding, standardizes competencies, and reduces support burdens across the Company’s expanding customer base.
Key Highlights:
- AI-Powered Training & Support: Inspira will deploy adaptive, AI-driven training modules, interactive simulations, and digital playbooks for troubleshooting and maintenance, enabling faster and more consistent proficiency.
- Personalized, On-Demand Knowledge: The Bites “AI Personal Knowledge Feed” will deliver personalized, real-time micro-content, updates, and compliance reminders, ensuring users always have the right information at the right time.
- Data-Driven Quality & Analytics: The integrated platform provides actionable analytics on training efficiency, adoption rates, and audit-readiness, supporting Inspira’s focus on measurable quality and continuous improvement.
- Built-In Value Layer: Bites’ AI capabilities will be incorporated as a built-in commercial value layer, enhancing Inspira’s customer experience and competitive differentiation.
- Joint Marketing & Innovation: Inspira and Bites will pursue joint marketing initiatives and continuous platform co-development, reinforcing sustained innovation and long-term value creation.
- Long-Term Strategic Options: The collaboration framework includes provisions to evaluate future strategic transactions or deeper commercial integration, underscoring the shared vision and growth potential of both organizations.
“By integrating Bites' AI engine directly into our ecosystem, we are transforming how medical teams learn, operate, and scale proficiency,” said Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies. “We expect this collaboration to significantly enhance operational consistency, expand adoption, and strengthen our global execution - ultimately driving measurable shareholder value.”
“Inspira is redefining digital transformation in medical devices,” said Tal Nagler Almog, Chief Operating Officer of Bites. “Our AI-based platform will empower Inspira’s global network with real-time, personalized knowledge delivery, setting a new industry standard for training and compliance.”
About Inspira Technologies
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The Company’s U.S. Food and Drug Administration -cleared INSPIRA™ ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures outside the U.S and serves as a foundation for the development of the INSPIRA ART500, a next-generation system designed to deliver oxygenation while patients remain awake and spontaneously breathing. Inspira Technologies is also advancing HYLA™, a proprietary blood sensor platform offering continuous, non-invasive monitoring. With multiple cleared products, a growing IP portfolio, and strategic streamlining of its operations, Inspira Technologies is increasingly positioned as an attractive platform within the life-support and MedTech landscape. The Company’s recent internal shifts may reflect broader alignment with long-term industry trends, including consolidation, cross-sector collaboration, and potential strategic partnerships. For more information, visit: https://inspira-technologies.com
About Bites Learning Ltd. Bites Learning Ltd. is a leading provider of an AI-based digital training and knowledge platform. Its solution leverages adaptive microlearning and a personalized AI knowledge feed to deliver on-demand, just-in-time guidance, helping global organizations accelerate onboarding, standardize competencies, and reduce support costs.
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the benefits and advnatages of collaboration with Bites, the Company’s expectation that this collaboration will expect this collaboration to significantly enhance operational consistency, expand adoption, and strengthen our global execution, ultimately driving measurable shareholder value, and that Bites’ technology will empower Inspira’s global network with real-time, personalized knowledge delivery and set a new standard for the industry. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov.
Company Contact
Inspira Technologies – Media Relations
Email: info@inspirao2.com
Phone: +972-9-9664485
FAQ
What did Inspira (IINN) announce on October 22, 2025 about Bites integration?
How will the Bites AI platform affect training for Inspira (IINN) devices?
Which Inspira products will include Bites’ AI capabilities for NASDAQ:IINN?
Will Inspira (IINN) track training performance after the Bites integration?
Does the Inspira and Bites agreement allow for deeper commercial integration or transactions?
